PubMed Health⌕ Search

PubMed · 15366241

Improving geocoding practices: evaluation of geocoding tools.

Abstract

This study examined the sources of error involved in geocoding, by systematically evaluating the strengths and weaknesses of three widely used tools for geocoding. We tested them against a random sample of addresses from a state administrative address master file and found considerable variation in identification of census block geocodes of addresses. This high variation was mainly attributable to differences in preprocessing of addresses before geocoding and the reference street data used for geocoding. Preprocessing includes not only parsing and standardizing, but also correcting addresses against the US Postal Service Zip+4 Database, the master mailing address database maintained and updated regularly by USPS.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Duck-Hye Yang, Lucy Mackey Bilaver, Oscar Hayes, Robert Goerge. 2004. Improving geocoding practices: evaluation of geocoding tools.. https://doi.org/10.1023/b%3Ajoms.0000032851.76239.e3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Epidemiology of myomas.

Fibroids are a prevalent disorder occurring in at least half of American reproductive-age women. In general, the incidence and size increases with age. Most women never attribute or report any symptoms from their fibroids, and because of this the actual contribution of disease to symptoms of pelvic pain,menstrual symptoms, and infertility is poorly understood. The presence of fibroids can lead to multiple and disabling difficulties. Fibroids may cause pain and menstrual bleeding to the point of anemia. Fibroids clearly reduce fertility,increase preterm labor and delivery, and markedly increase the risk for cesarean delivery. Because the incidence varies according to population of interest, fibroids may explain some health disparities in different populations. For example,African Americans have a relatively poor outcome with assisted reproductive techniques compared with whites. Controlling for fibroid disease may explain this disparity, at least in part. Fibroids represent a tremendous public health burden on women and economic cost on society. Strategies to prevent, limit growth, and treat nonsurgically are needed. Fundamental and significant questions remain about fibroid disease,such as whether different clinical disease phenotypes (multiple versus single leiomyomas) contribute equally to symptoms and possess an equal likelihood of disease progression. For epidemiologic assessment of disease, a scoring system is urgently needed. Well-designed, controlled, prospective studies are still needed to define the natural history and correlate the presence of disease with symptomatology in women.

Epidemiologic Studies↗

The genetic heterogeneity of uterine leiomyomata.

Research investigating the genetics of UL has already been successful in gathering epidemiologic evidence for heritability, establishing the clonal and mosaic nature of these tumors, correlating genotypic and phenotypic characteristics, defining cytogenetic subgroups, and identifying specific genes involved in tumorigenesis. Although UL are known to be benign tumors, the impact they have on the lives of so many women can only be described as "malignant". For this reason, continuing the quest to ascertain the genes, functions, and mechanisms integral to UL development is absolutely imperative. Genetic tests for personalized medical management of women with fibroids is at the threshold for providing the most appropriate treatments (Fig. 3), and combined with developing less invasive therapies portends a brighter future for a major health problem for women.

Epidemiologic Studies↗